Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ammonia detoxification pathway enzymes comprise a group of enzymes essential for the conversion of toxic ammonia, produced primarily from amino acid breakdown, into excretable compounds such as urea and glutamine. The **urea cycle** is the principal route and takes place predominantly in the liver, utilizing enzymes such as carbamoyl phosphate synthetase I (CPS1), ornithine transcarbamylase, argininosuccinate synthetase, argininosuccinate lyase, and arginase[1][5][7]. **Glutamine synthetase** provides a parallel backup route by incorporating ammonia into glutamine, which is especially important in the brain, muscle, and perivenous hepatocytes[1][3][4]. Other supporting enzymes include glutamate dehydrogenase (in the glutamate dehydrogenase reaction), alanine aminotransferase, and enzymes of the purine nucleotide cycle[2]. Disruption in any of these enzymes may result in pathological ammonia accumulation, manifesting as metabolic disorders—including hepatic encephalopathy and inherited urea cycle disorders—with life-threatening neurological consequences. The pathway is a **therapeutic target in the context of hyperammonemia**, but as a term, "Ammonia detoxification pathway enzymes" lacks specificity, referring not to a single molecular entity but to a functional group of biochemically related enzymes[2][5][6]. This target name is too broad and refers to a group of enzymes and pathways rather than a single, specific molecular target. For structured data extraction or drug targeting, it is essential to specify individual enzymes, such as "Carbamoyl phosphate synthetase 1" or "Glutamine synthetase," rather than this pathway-level term.
Activation of alternative ammonia elimination paths (e.g., conjugation with benzoate to form hippurate, with phenylacetate to form phenylacetylglutamine) - Enhancement or support of urea cycle function - Detoxification through increased excretion of alternative nitrogen carriers
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ammonia detoxification pathway enzymes.